Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Practolol in acute myocardial infarction.

J M Barber, D M Boyle, N C Chaturvedi

    Acta Medica Scandinavica. Supplementum
    |January 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Aging human abdominal subcutaneous white adipose tissue at single cell resolution.

    Aging cell·2024
    Same author

    Implications of United States Supreme Court's ruling on Dobbs vs Jackson Women's Health Organization: perspective of physicians caring for critically ill fetuses and newborns.

    Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2022
    Same author

    Canadian Surgery Forum.

    Canadian journal of surgery. Journal canadien de chirurgie·2022
    Same author

    An investigation of lumbar spine magnetic resonance referrals in two Irish university teaching centres: Radiology clinical judgement versus iRefer guideline compliance.

    Radiography (London, England : 1995)·2022
    Same author

    Edge Thomson scattering diagnostic on COMPASS tokamak: installation, calibration, operation, improvements.

    The Review of scientific instruments·2014
    Same author

    An 11-year review of levetiracetam ingestions in children less than 6 years of age.

    Clinical toxicology (Philadelphia, Pa.)·2014

    Practolol did not reduce overall mortality in acute myocardial infarction patients over two years. However, it significantly lowered mortality in patients with an initial heart rate over 100 beats per minute up to one year.

    Area of Science:

    • Cardiology
    • Pharmacology

    Background:

    • Beta-adrenergic blocking drugs theoretically aid acute myocardial infarction management due to reduced left ventricular work and antiarrhythmic effects.
    • Practolol is a cardio-selective beta-blocker with intrinsic sympathomimetic action but no local anesthetic effect.
    • Practolol has shown efficacy in post-infarction arrhythmias and reducing necrosis in early infarction.

    Purpose of the Study:

    • To evaluate the efficacy of practolol in managing coronary heart disease over a two-year period.
    • To assess practolol's impact on overall mortality, infarction, and sudden death in patients with coronary heart disease.
    • To investigate practolol's effect on mortality in acute myocardial infarction patients, particularly those with elevated heart rates.

    Main Methods:

    • A two-year, double-blind trial involving patients with coronary heart disease.

    Related Experiment Videos

  • Inclusion criteria: acute myocardial infarction (n=298) and coronary heart disease (n=484).
  • Subgroup analysis for patients with initial heart rate > 100 bpm.

    • Main Results:

    • No significant reduction in overall mortality was observed in 298 acute myocardial infarction patients.
    • Mortality was significantly reduced up to one year in patients with an initial heart rate > 100 bpm.
    • No significant reduction in infarction or sudden death was found in 484 coronary heart disease patients over two years.

    Conclusions:

    • Practolol did not demonstrate a significant benefit in reducing overall mortality or preventing infarction/sudden death in coronary heart disease patients over two years.
    • A potential short-term mortality benefit was observed in a specific subgroup of acute myocardial infarction patients with high initial heart rates.
    • Further research may be warranted to explore specific indications or patient populations for practolol in cardiovascular disease management.